A surprising discovery from Rockefeller University suggests that a common amino acid could play a powerful role in protecting against cancer and viral infections. Scientists found that low arginine levels interfere with the immune system's ability to recognize dangerous cells, while increasing arginine intake reduced colon cancer tumors and improved viral infection outcomes in mice. Even more remarkably, giving mice arginine after they contracted influenza helped them recover. The findings, published in the journal Cell, add to a growing body of research into how nutrition influences immune function and could eventually inform new approaches to supporting the body's natural defenses.
The research team cautioned that the results are preliminary and based on animal models, meaning it is too early to draw conclusions about human health. Arginine, an amino acid found in foods such as meat, dairy, and nuts, is already available as a dietary supplement, but researchers stressed that people should not self-medicate or alter their diets based on these findings without medical guidance. Further clinical trials will be needed to determine whether arginine supplementation offers similar benefits in humans and to establish safe and effective dosages. The study nonetheless opens a promising avenue for future research into immune-boosting therapies.
Independent reporting synthesized from primary wires and global correspondents.